<DOC>
	<DOCNO>NCT02864888</DOCNO>
	<brief_summary>The primary objective protocol study investigate effect Antineoplaston therapy QT/QTc interval study subject age 3 21 year newly-diagnosed , diffuse , intrinsic brainstem glioma . This investigation conduct parallel phase 3 efficacy safety study combination Antineoplaston therapy + radiation vs. radiation alone ( BRI-BT-52 ) .</brief_summary>
	<brief_title>Effect Antineoplaston Therapy QT/QTc Interval In Subjects With Diffuse , Intrinsic , Brainstem Glioma</brief_title>
	<detailed_description>QT/QTc interval prolongation investigate first two week subject participation parallel phase 3 study . The pre-cordial lead lead II utilized determine QT/QTc prolongation . Descriptive information provide change T U wave morphology . The percentage subject therapy group worsen T U wave morphology document . Discrete U wave exclude QT/QTc interval measurement . Except pre-therapy ECGs , ECGs perform one ANP therapy infusion daily , afternoon infusion account diurnal variation QT/QTc interval . The study subject rest supine position 30 minute prior ECG study . The baseline QTc derive 3 ECGs take day 1 hour precede first Antineoplaston therapy infusion first radiation session .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>Enrolled BRIBT52 Not enrol BRIBT52</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Diffuse , intrinsic brain stem glioma</keyword>
	<keyword>QT/QTc interval</keyword>
	<keyword>Radiation</keyword>
	<keyword>Antineoplaston therapy</keyword>
</DOC>